Fiellin DA - Search Results

1

HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study.

Altice FL, Bruce RD, Lucas GM, Lum PJ, Korthuis PT, Flanigan TP, Cunningham CO, Sullivan LE, Vergara-Rodriguez P, Fiellin DA, Cajina A, Botsko M, Nandi V, Gourevitch MN, Finkelstein R; BHIVES Collaborative. Altice FL, et al. Among authors: fiellin da. J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1(Suppl 1):S22-32. doi: 10.1097/QAI.0b013e318209751e. J Acquir Immune Defic Syndr. 2011. PMID: 21317590 Free PMC article. Clinical Trial.

2

Pharmacologic treatment of heroin-dependent patients.

O'Connor PG, Fiellin DA. O'Connor PG, et al. Among authors: fiellin da. Ann Intern Med. 2000 Jul 4;133(1):40-54. doi: 10.7326/0003-4819-133-1-200007040-00008. Ann Intern Med. 2000. PMID: 10877739 Review.

3

Treatment of heroin dependence with buprenorphine in primary care.

Fiellin DA, Pantalon MV, Pakes JP, O'Connor PG, Chawarski M, Schottenfeld RS. Fiellin DA, et al. Am J Drug Alcohol Abuse. 2002;28(2):231-41. doi: 10.1081/ada-120002972. Am J Drug Alcohol Abuse. 2002. PMID: 12014814

4

Coordination of medical care and opioid dependence treatment in primary care: a case report.

Fiellin DA, Rosenheck RA, Kosten TR. Fiellin DA, et al. Subst Abus. 2003 Mar;24(1):43-6. doi: 10.1080/08897070309511532. Subst Abus. 2003. PMID: 12652094 No abstract available.

5

Hepatitis C and HIV infections: implications for clinical care in injection drug users.

Sullivan LE, Fiellin DA. Sullivan LE, et al. Among authors: fiellin da. Am J Addict. 2004 Jan-Feb;13(1):1-20. doi: 10.1080/10550490490265271. Am J Addict. 2004. PMID: 14766434 Review.

6

Substance use of disorders in HIV-infected patients: impact and new treatment strategies.

Fiellin DA. Fiellin DA. Top HIV Med. 2004 Jul-Aug;12(3):77-82. Top HIV Med. 2004. PMID: 15310938 Free article. Review.

7

Consensus statement on office-based treatment of opioid dependence using buprenorphine.

Fiellin DA, Kleber H, Trumble-Hejduk JG, McLellan AT, Kosten TR. Fiellin DA, et al. J Subst Abuse Treat. 2004 Sep;27(2):153-9. doi: 10.1016/j.jsat.2004.06.005. J Subst Abuse Treat. 2004. PMID: 15450648 Review.

8

Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users.

Sullivan LE, Metzger DS, Fudala PJ, Fiellin DA. Sullivan LE, et al. Among authors: fiellin da. Addiction. 2005 Feb;100(2):150-8. doi: 10.1111/j.1360-0443.2004.00963.x. Addiction. 2005. PMID: 15679744 Review.

9

The prevalence and impact of alcohol problems in major depression: a systematic review.

Sullivan LE, Fiellin DA, O'Connor PG. Sullivan LE, et al. Among authors: fiellin da. Am J Med. 2005 Apr;118(4):330-41. doi: 10.1016/j.amjmed.2005.01.007. Am J Med. 2005. PMID: 15808128 Review.

10

The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?

Sullivan LE, Chawarski M, O'Connor PG, Schottenfeld RS, Fiellin DA. Sullivan LE, et al. Among authors: fiellin da. Drug Alcohol Depend. 2005 Jul;79(1):113-6. doi: 10.1016/j.drugalcdep.2004.12.008. Drug Alcohol Depend. 2005. PMID: 15943950 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

392 results

Search Page